The Short‐Term Health Effects of Dealcoholised Red Wine: A Systematic Review and Meta‐Analysis
Drug and Alcohol Review · 2025-11 · 44 (7) · 2091-2105
DOI: 10.1111/dar.70047 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Drug and Alcohol Review, online erschienen am 08.10.2025. Verfasst von Tesfa M Yimer und 9 weiteren Autor:innen. Beteiligte Einrichtung: National Centre for Youth Substance Use Research, School of Psychology, The University of Queensland, Brisbane, Australia. Hauptthemen laut MEDLINE: Wine. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 78 Literaturangaben. Gefördert von: NHMRC, Australian Government, National Health and Medical Research Council.
Abstract (Originalsprache)
Issues Health benefits of red wine are claimed and attributed to its high polyphenol content, but these claims are controversial due to the array of known alcohol‐related harms. We undertook a systematic review and meta‐analysis to identify whether there are health benefits of dealcoholised red wine. Approach We searched PubMed, Embase, Scopus, PsycINFO and Web of Science for randomised controlled or cross‐over trials. Comparisons analysed were: (i) dealcoholised red wine versus red wine; and (ii) dealcoholised red wine versus water. Health outcomes included serum/plasma antioxidant capacity, cardiovascular function, immune function, liver function, metabolism, microbiome diversity and inflammatory markers. Random effects meta‐analyses were performed to estimate standardised mean differences (SMD = d). Key Findings From 865 identified records, we included 36 studies. Dealcoholised red wine was associated with increased serum/plasma antioxidant capacity ( d = 0.72; 95% CI [0.42, 1.01]) and microbiome diversity ( d = 0.63 [0.32, 0.93]) compared to water, but has less effect on microbiome diversity ( d = −0.32 [−0.52, −0.11]) compared to red wine. No significant differences were observed in other health outcomes.
Implications
Dealcoholised red wine may have some short‐term health benefits, but there is uncertainty on long‐term population‐level impacts; therefore, the precautionary principle should be applied.
Conclusions
Dealcoholised red wine may have some short‐term health benefits in increasing serum/plasma antioxidant capacity and microbiome diversity, but the evidence is limited by small sample size, short‐term follow‐up, and heterogeneous studies. These data do not support a rationale for drinking red wine for purported health benefits due to the known long‐term health harms of alcohol consumption.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Centre for Youth Substance Use Research, School of Psychology, The University of Queensland, Brisbane, Australia.
- Medical School, The University of Queensland, Brisbane, Australia.
ORCID-Profile: Gary C K Chan, Daniel Stjepanović, Tianze Sun, Janni Leung
Förderung
- NHMRC
- Australian Government
- National Health and Medical Research Council
Zitieren
APA
Yimer, T. M., Chan, G. C. K., Stjepanović, D., Sun, T., Shin, D., Lucey, M., Choi, J., Saunders, J. B., Connor, J. P., & Leung, J. (2025). The Short‐Term Health Effects of Dealcoholised Red Wine: A Systematic Review and Meta‐Analysis. Drug and Alcohol Review, 44(7), 2091-2105. https://doi.org/10.1111/dar.70047
Vancouver
Yimer TM, Chan GCK, Stjepanović D, Sun T, Shin D, Lucey M, et al. The Short‐Term Health Effects of Dealcoholised Red Wine: A Systematic Review and Meta‐Analysis. Drug and Alcohol Review. 2025;44(7):2091-2105. doi:10.1111/dar.70047
BibTeX
@article{Yimer2025,
author = {Yimer, Tesfa M and Chan, Gary C K and Stjepanović, Daniel and Sun, Tianze and Shin, Dongwoo and Lucey, Meghan and Choi, Jisu and Saunders, John B and Connor, Jason P and Leung, Janni},
title = {The Short‐Term Health Effects of Dealcoholised Red Wine: A Systematic Review and Meta‐Analysis},
journal = {Drug and Alcohol Review},
year = {2025},
volume = {44},
number = {7},
pages = {2091--2105},
doi = {10.1111/dar.70047}
}
EUVIMED